Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests as well as drug delivery in the field of prevention, detection and treatment of infectious diseases and oncology. Novosanis is a Belgian company endorsed on multiple occasions nationally and internationally for its solutions and is ISO13485 certified. Novosanis prospers in user-friendly and clever medical devices meeting all regulatory and quality requirements for self-sampling and drug delivery solutions that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user. Novosanis has two business units: Delivery Solutions: the VAX-ID™ drug delivery platform is a patented and proven platform of injection devices suited for accurate drug delivery of e.g. therapeutic, prophylactic and allergy vaccines in the dermal layer of the skin. Sampling Solutions: Colli-Pee™ is a patented sampling device suited for standardized and guaranteed collection of first-void urine (first 20ml of the urine flow) allowing improved detection of infectious diseases as well as early stage cancer. Colli-Pee™ is in a commercial stage. It is CE-marked and FDA listed. More information on www.novosanis.com of contact us for all your inquiries welcome@novosanis.comFollow us on Twitter: @Novosanis

medical device in vitro diagnostics vaccination urine collection first-void urine collection intradermal vaccination infectious diseases colli-pee vax-id oncology diagnostics medical device in vitro diagnostics vaccination urine collection first-void urine collection intradermal vaccination infectious diseases colli-pee vax-id oncology diagnostics medical device in vitro diagnostics vaccination urine collection first-void urine collection intradermal vaccination infectious diseases colli-pee vax-id oncology diagnostics